Emerald Advisers
RVMD icon

Emerald Advisers’s Revolution Medicines RVMD Stock Holding History

Emerald Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$465K Buy
+2,266
New +$449K 0.01% 183
2020
Q2 		– Sell
-50,487
Closed -$1.11M – 333
2020
Q1 		$1.11M Buy
+50,487
New +$1.4M 0.06% 131

Other funds holding RVMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Emerald Advisers's RVMD Position: Q3 2026 in Review

Emerald Advisers opened a new position in Revolution Medicines (RVMD) in Q3 2026: 2,266 shares worth $465K. The stake represents 0.01% of the portfolio and ranks #183 among its holdings. This is a return to the name: Emerald Advisers previously reported a position in RVMD as recently as Q1 2020.

Emerald Advisers first reported a position in RVMD in Q1 2020 and has held it in 2 quarters since. The position peaked at $1.11M in Q1 2020. 358 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Emerald Advisers held 2,266 shares of Revolution Medicines worth $465K as of Q3 2026.
  • Revolution Medicines was a new Emerald Advisers position in Q3 2026.
  • Revolution Medicines made up 0.01% of Emerald Advisers's portfolio in Q3 2026, its #183 holding.
  • Emerald Advisers first reported a position in Revolution Medicines in Q1 2020 and has held it in 2 quarters since.
  • Emerald Advisers's Revolution Medicines position peaked at $1.11M in Q1 2020.
  • 358 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Emerald Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.